Health Canada accepts Cipher tramadol filing
March 26, 2010 by leonardzehr · Leave a Comment
Cipher Pharmaceuticals’ (TSX:DND) new drug submission to Health Canada for cip-tramadol ER, its extended-release formulation of tramadol, has been accepted for review. Cipher expects the review to be completed by early 2011. “The Canadian market for tramadol is strong and growing, with sales of approximately $50 million last year, a 30 per cent increase over [...]
Listen to BioTuesdays 
